Ascendia

  MARKET NEWS

FDA Approves Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata
AC Immune Unveils Novel Therapeutic ADC Technology for Improved Efficacy in Neurodegenerative Diseases
GeoVax Announces Phase 2 Plans for Cancer Therapy Following Clinical Advisory Committee Review
Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer’s Disease
GSK Leverages Genedata Biologics as End-to-End Automation & Data Science Platform
Ocular Therapeutix Announces First Patients Enrolled in Phase 3 SOL-R Wet AMD Study
Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX2-73 in Fragile X Syndrome (Major Cause of Autism)
IMUNON Announces 11.1 Month Increase in Overall Survival in Patients With Newly Diagnosed, Advanced Ovarian Cancer Treated With IMNN-001
Sapio Sciences & Zifo Announce Strategic Partnership
Dosing Completed in 115 Participant Bioavailability/Bioequivalence Clinical Trial for Proprietary Sleep Apnea Drug Candidate

  EXPERT CONTENT & RESOURCES

Presentation: Strategies for Amorphous Solid Dispersion Product Development

Presentation: Strategies for Amorphous Solid Dispersion Product Development

In this presentation, Dr. Schlesinger demonstrates how to leverage a combination of measured and calculated molecular properties, bio-performance modeling, and a strategic understanding of the product TPP to identify a technology to enable exposure and an appropriate drug product design…..

ALBA SUCCESS CASE

Container Selection for a Highly Sensitive Drug Product: A Success Story

For new drug products, it is essential that pharmaceutical companies utilize the experience of container suppliers as early as possible.

Meet Gaelic Laboratories, Your Trusted Testing & Manufacturing Partner

Meet Gaelic Laboratories, Your Trusted Testing & Manufacturing Partner

Gaelic Laboratories today announces its new website, which contains details about this world-class Beta-Lactam (penicillin) manufacturer’s….

How AbbVie Operations & Contract Manufacturing Has Prepared Global Parenteral Sites for the Annex 1 Compliance Requirement

How AbbVie Operations & Contract Manufacturing Has Prepared Global Parenteral Sites for the Annex 1 Compliance Requirement

This article explains the key changes that pharmaceutical companies and CMOs engaged in manufacturing and fill-finish need to consider, as well as what AbbVie Contract Manufacturing (AbbVie CMO) is doing to ensure its global operations and aseptic fill-finish sites are in compliance with the revised regulations….

  FEATURED EDITORIAL

  COMPANY PROFILE

BASF Pharma Solutions is a leading provider of innovative and high-quality excipients and APIs for the pharmaceutical industry. Our dedicated team of industry experts, supported by our cutting-edge digital solutions, works closely with customers to develop efficient and reliable formulations. Based in Florham Park, United States, our operations span across the globe, with production facilities that spread across multiple continents, we are able to provide support and solutions to pharmaceutical industries worldwide. At BASF, we prioritize the production of pharmaceutical ingredients in accordance with the highest quality standards. With over 75 years of experience, we offer the expertise and continuity necessary to meet the diverse needs of your pharmaceutical business. Click here for more.

  WHITEPAPERS & WEBINARS

WEBINAR - Development of Orally Delivered GLP-1 Therapeutics…From Diabetes to Obesity and Beyond

WEBINAR - Development of Orally Delivered GLP-1 Therapeutics…From Diabetes to Obesity and Beyond

Join Quotient Sciences’ experts on July 18 as we explore the latest developments in orally-delivered GLP-1 agonists, the potential for these therapeutics and overcoming the manufacturing challenges.

  WHITEPAPERS & WEBINARS

WHITEPAPER - Unlock the Secrets of Spray Drying for Sticky APIs

WHITEPAPER - Unlock the Secrets of Spray Drying for Sticky APIs

It is widely reported that 40% of New Chemical Entities (NCEs) in the pharmaceutical industry are poorly soluble, leading to inadequate bioavailablity. Spray drying is one of the most promising particle engineering technologies used to overcome solubility issues in active …

WHITEPAPER - Versatility of Geleol™ Mono- and Diglycerides NF

WHITEPAPER - Versatility of Geleol™ Mono- and Diglycerides NF

By: Jasmine Musakhanian, Senior Scientific Director, Gattefossé

INTRODUCTION

Mono and diglycerides, also known as partial glycerides, are versatile lipid excipients that play a pivotal role in the realization of drug products and nutraceuticals. Some well-known excipients in this category are …

WHITEPAPER - Efficient Development of Miniature Drug-Loaded Implants

WHITEPAPER - Efficient Development of Miniature Drug-Loaded Implants

Drug-eluting implants offer a unique approach to overcoming challenges associated with traditional drug delivery methods. They can provide sustained, continuous release of a therapeutic at the desired site of action.

Download our latest white paper, jointly authored with MeltPrep, to …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

August 14 – Lyophilization Manufacturing
August 21 – Excipients